Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expressionMalte Roerden, Stefani Spranger, Byungji Kim et al.|Journal for ImmunoTherapy of Cancer|2024Cited by 21
Validation and quantification of peptide antigens presented on MHCs using SureQuantOwen Leddy, Forest M. White, Yufei Cui et al.|Nature Protocols|2024Cited by 11
Impact of Mantle Cell Lymphoma Contamination of Autologous Stem Cell Grafts on Outcome after High-Dose ChemotherapyMalte Roerden, Juliane S. Walz|Cancers|2021Cited by 2